{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T20:01:20Z","timestamp":1759694480762,"version":"3.40.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.mehy.2013.03.023","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T17:16:55Z","timestamp":1365441415000},"page":"823-826","source":"Crossref","is-referenced-by-count":11,"title":["Black bile: Are elevated monoamines an etiological factor in some cases of major depression?"],"prefix":"10.1016","volume":"80","author":[{"given":"Paul J.","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2013.03.023_b0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0010","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1192\/bjp.113.504.1237","article-title":"The biochemistry of affective disorders","volume":"113","author":"Coppen","year":"1967","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0015","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/00004714-199606002-00001","article-title":"Synaptic effects of antidepressants","volume":"16","author":"Richelson","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.mehy.2013.03.023_b0020","doi-asserted-by":"crossref","first-page":"478","DOI":"10.20452\/pamw.743","article-title":"First-line pharmacotherapies for depression \u2013 what is the best choice?","volume":"119","author":"Koenig","year":"2009","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.mehy.2013.03.023_b0025","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic\u2013adrenergic hypothesis of mania and depression","volume":"2","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2013.03.023_b0030","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/archpsyc.1981.01780360103012","article-title":"Plasma MHPG in rapid cyclers and healthy twins","volume":"38","author":"Jimerson","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0035","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1098\/rstb.2012.0212","article-title":"Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression","volume":"367","author":"Massart","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.mehy.2013.03.023_b0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S003329170004962X","article-title":"3-Methoxy-4-hydroxyphenylglycol in depression","volume":"3","author":"Shaw","year":"1973","journal-title":"Psychol. Med."},{"key":"10.1016\/j.mehy.2013.03.023_b0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00427352","article-title":"Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness","volume":"64","author":"Coppen","year":"1979","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.mehy.2013.03.023_b0050","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration","volume":"5","author":"Kirsch","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.mehy.2013.03.023_b0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0091-3057(02)01047-X","article-title":"Rapid habituation of hippocampal serotonin and norepinephrine release and anxiety-related behaviors, but not plasma corticosterone levels, to repeated footshock stress in rats","volume":"74","author":"Hajos-Korcsok","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.mehy.2013.03.023_b0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneumeth.2004.05.017","article-title":"Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression","volume":"140","author":"Mathews","year":"2004","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.mehy.2013.03.023_b0065","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0006-3223(03)00696-6","article-title":"Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice","volume":"54","author":"Lira","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0070","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neuropharm.2011.08.045","article-title":"Pharmacological modulation of stress-induced behavioral changes in the light\/dark exploration test in male C57BL\/6J mice","volume":"62","author":"Ihne","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2013.03.023_b0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.mehy.2013.03.023_b0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jad.2005.05.007","article-title":"Subthreshold depression is linked to the functional polymorphism of the 5HT transporter gene","volume":"87","author":"Gonda","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.mehy.2013.03.023_b0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/appi.ajgp.10.2.185","article-title":"Allelic differences in the serotonin transporter-linked polymorphic region in geriatric depression","volume":"10","author":"Steffens","year":"2002","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(91)90035-A","article-title":"The effect of the novel antidepressant tianeptine on the concentration of 5-hydroxytryptamine in rat hippocampal dialysates in vivo","volume":"30","author":"Whitton","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2013.03.023_b0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0924-977X(96)00025-9","article-title":"Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems","volume":"6","author":"Bourin","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.mehy.2013.03.023_b0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0006-3223(91)90041-J","article-title":"The cholinergic-adrenergic hypothesis of depression reexamined using clonidine, metoprolol, and physostigmine in an animal model","volume":"29","author":"Hasey","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0105","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/FBP.0b013e32830cd80f","article-title":"Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions","volume":"19","author":"Perona","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.mehy.2013.03.023_b0110","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0895-4356(96)00017-0","article-title":"The incidence of depression in new users of beta-blockers and selected antihypertensives","volume":"49","author":"Gerstman","year":"1996","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.mehy.2013.03.023_b0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2007-1019557","article-title":"Noradrenergic transmission in depression: under- or overfunction?","volume":"14","author":"Waldmeier","year":"1981","journal-title":"Pharmacopsychiatria"},{"key":"10.1016\/j.mehy.2013.03.023_b0120","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/da.20001","article-title":"Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline","volume":"19","author":"Joyce","year":"2004","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.mehy.2013.03.023_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1176\/ajp.152.1.31","article-title":"Atypical depression: clinical aspects and noradrenergic function","volume":"152","author":"Asnis","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0130","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/sj.npp.1300191","article-title":"Elevated concentrations of CRF in the locus coeruleus of depressed subjects","volume":"28","author":"Bissette","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2013.03.023_b0135","first-page":"S239","article-title":"Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression","volume":"2","author":"Louis","year":"1975","journal-title":"Clin. Sci. Mol. Med. Suppl."},{"key":"10.1016\/j.mehy.2013.03.023_b0140","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","volume":"166","author":"Nelson","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jad.2010.08.009","article-title":"The functional Val158Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study","volume":"129","author":"Aberg","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.mehy.2013.03.023_b0150","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.comppsych.2011.07.005","article-title":"The association between anomalous self-experience and suicidality in first-episode schizophrenia seems mediated by depression","volume":"53","author":"Haug","year":"2012","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(55)92118-8","article-title":"Reserpine in the treatment of anxious and depressed patients","volume":"269","author":"Davies","year":"1955","journal-title":"Lancet"},{"issue":"Suppl. 5","key":"10.1016\/j.mehy.2013.03.023_b0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4088\/JCP.8157su1c.04","article-title":"Evidence for S-adenosyl-l-methionine (SAM-e) for the treatment of major depressive disorder","volume":"70","author":"Papakostas","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1465-3362.2011.00401.x","article-title":"Exposure to dysfunctional parenting and trauma events and posttraumatic stress profiles among a treatment sample with coexisting depression and alcohol use problems","volume":"31","author":"Bailey","year":"2012","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.mehy.2013.03.023_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","article-title":"Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia","volume":"41","author":"Grace","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2013.03.023_b0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0893-133X(02)00301-9","article-title":"Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex","volume":"27","author":"Page","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2013.03.023_b0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(01)00079-1","article-title":"Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex","volume":"40","author":"Yoshino","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.mehy.2013.03.023_b0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jad.2006.01.028","article-title":"Clinical variables related to antidepressant-induced mania in bipolar disorder","volume":"92","author":"Mundo","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.mehy.2013.03.023_b0190","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1399-5618.2008.00637.x","article-title":"Treatment-emergent mania\/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder","volume":"10","author":"Gao","year":"2008","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.mehy.2013.03.023_b0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004850-200211000-00009","article-title":"Dysphoric mania induced by high-dose mirtazapine: a case for \u2018norepinephrine syndrome\u2019?","volume":"17","author":"Bhanji","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.mehy.2013.03.023_b0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2013.03.023_b0205","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0022-3565(25)39523-6","article-title":"Inhibition of norepinephrine release from rat cortex slices by opioids: differences among agonists in sensitivities to antagonists suggest receptor heterogeneity","volume":"267","author":"Kim","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mehy.2013.03.023_b0210","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.neuropharm.2012.06.003","article-title":"Presynaptic \u03b12-adrenoceptors control the inhibitory action of presynaptic CB1 cannabinoid receptors on prefrontocortical norepinephrine release in the rat","volume":"63","author":"Richter","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2013.03.023_b0215","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.mehy.2013.03.023_b0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(00)02013-8","article-title":"Monoamines and sleep: microdialysis findings in pons and amygdala","volume":"860","author":"Shouse","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.mehy.2013.03.023_b0225","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/jnr.20602","article-title":"Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep\u2013wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats","volume":"81","author":"Lena","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mehy.2013.03.023_b0230","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11920-007-0061-3","article-title":"The STAR\u2217D Project results: a comprehensive review of findings","volume":"9","author":"Warden","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.mehy.2013.03.023_b0235","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/156720510792231775","article-title":"Is elevated norepinephrine an etiological factor in some cases of Alzheimer\u2019s disease?","volume":"7","author":"Fitzgerald","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.mehy.2013.03.023_b0240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.seizure.2010.04.011","article-title":"Is elevated norepinephrine an etiological factor in some cases of epilepsy?","volume":"19","author":"Fitzgerald","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.mehy.2013.03.023_b0245","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.24063","article-title":"Is norepinephrine an etiological factor in some types of cancer?","volume":"124","author":"Fitzgerald","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mehy.2013.03.023_b0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1474-8665.2009.00442.x","article-title":"Is elevated noradrenaline an aetiological factor in a number of diseases?","volume":"29","author":"Fitzgerald","year":"2009","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.mehy.2013.03.023_b0255","first-page":"1","article-title":"Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer","volume":"2","author":"Fitzgerald","year":"2010","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.mehy.2013.03.023_b0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/CLEP.S33695","article-title":"Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint","volume":"4","author":"Fitzgerald","year":"2012","journal-title":"Clin. Epidemiol."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713001424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713001424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T03:36:49Z","timestamp":1745984209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987713001424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0306987713001424"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2013.03.023","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}